Wellington Management Group LLP Has $23.04 Million Position in Church & Dwight Co., Inc. (NYSE:CHD)

Wellington Management Group LLP increased its holdings in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 25.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 219,992 shares of the company's stock after purchasing an additional 44,026 shares during the period. Wellington Management Group LLP owned approximately 0.09% of Church & Dwight worth $23,035,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. YANKCOM Partnership acquired a new stake in shares of Church & Dwight in the 4th quarter valued at $25,000. Versant Capital Management Inc lifted its holdings in Church & Dwight by 224.4% during the 4th quarter. Versant Capital Management Inc now owns 266 shares of the company's stock valued at $28,000 after purchasing an additional 184 shares during the last quarter. Bank of Jackson Hole Trust acquired a new position in Church & Dwight in the fourth quarter valued at about $43,000. Golden State Wealth Management LLC bought a new stake in Church & Dwight during the fourth quarter worth about $51,000. Finally, Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Church & Dwight by 50.5% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 575 shares of the company's stock worth $60,000 after buying an additional 193 shares in the last quarter. Institutional investors and hedge funds own 86.60% of the company's stock.

Church & Dwight Trading Up 0.5 %

CHD traded up $0.47 during trading on Friday, reaching $104.24. 1,524,266 shares of the company's stock were exchanged, compared to its average volume of 1,505,147. The company's fifty day moving average price is $107.28 and its 200-day moving average price is $106.07. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70. The firm has a market capitalization of $25.65 billion, a PE ratio of 43.98, a P/E/G ratio of 3.32 and a beta of 0.55. Church & Dwight Co., Inc. has a fifty-two week low of $96.35 and a fifty-two week high of $116.46.

Church & Dwight (NYSE:CHD - Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.77 EPS for the quarter, meeting analysts' consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same period in the prior year, the firm earned $0.65 earnings per share. As a group, equities analysts forecast that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Friday, February 14th were paid a dividend of $0.295 per share. This is a positive change from Church & Dwight's previous quarterly dividend of $0.28. The ex-dividend date was Friday, February 14th. This represents a $1.18 annualized dividend and a yield of 1.13%. Church & Dwight's dividend payout ratio (DPR) is presently 49.79%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Wells Fargo & Company boosted their target price on Church & Dwight from $115.00 to $120.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Truist Financial boosted their price objective on Church & Dwight from $110.00 to $115.00 and gave the stock a "buy" rating in a research note on Monday, February 3rd. JPMorgan Chase & Co. decreased their target price on Church & Dwight from $106.00 to $98.00 and set an "underweight" rating on the stock in a report on Friday. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $105.00 price target on shares of Church & Dwight in a report on Monday, February 3rd. Finally, Piper Sandler decreased their price objective on shares of Church & Dwight from $128.00 to $126.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $111.44.

Insider Activity at Church & Dwight

In other Church & Dwight news, EVP Rene Hemsey sold 11,060 shares of Church & Dwight stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $109.98, for a total value of $1,216,378.80. Following the sale, the executive vice president now owns 6,437 shares of the company's stock, valued at $707,941.26. This trade represents a 63.21 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Maynadier Patrick D. De sold 54,510 shares of the business's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $115.98, for a total value of $6,322,069.80. Following the completion of the sale, the executive vice president now owns 10,497 shares in the company, valued at $1,217,442.06. The trade was a 83.85 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 65,570 shares of company stock worth $7,538,449. 2.00% of the stock is currently owned by company insiders.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.